Category: News and Press
National Holdings Corporation to Acquire Full-Service Investment Firm Winslow, Evans & Crocker, Inc.
NEW YORK, NY, August 26, 2019 – National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking and asset management firm providing a wide array of services, today announced that it has entered into a definitive purchase agreement to acquire Winslow, Evans & Crocker, Inc., an employee-owned full-service investment […]
National Holdings Corporation Adds Strategic New Hires to its Broker-Dealer Subsidiary
NEW YORK, NY, August 19, 2019 –National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a full-service independent brokerage, investment banking, insurance, accounting and asset management firm, today announced the addition of several strategic new hires to its broker-dealer subsidiary, National Securities Corporation (member FINRA/SIPC): Bill Washington joins as Managing Director, Chief Strategy Officer Mark […]
National Holdings Corporation Reports Financial Results for the Fiscal Third Quarter 2019
Conference call to be held today, August 15, 2019 at 8:30 AM ET NEW YORK, NY, August 15, 2019 – National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced its financial results for the […]
Eyenovia Inc. Prices Public Offering of Common Stock
 National Securities Corporation has acted as the Co-Manager in the Follow-On Offering of Eyenovia, Inc. ORIGINAL PRESS RELEASE RE-POSTED FROM NASDAQ Eyenovia, Inc. Prices Public Offering of Common Stock NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented […]
National Securities Acts as Exclusive Financial Advisor to Interpace Diagnostics in $23.5M Acquisition of BioPharma Business
ORIGINAL PRESS RELEASE BELOW RE-POSTED FROM GLOBENEWSWIRE Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners PARSIPPANY NJ, July 15, 2019 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business […]